Serina Therapeutics, Inc. Share Price & Technical Analysis
SER · $1.98 (+4.76%)
Healthcare / Biotechnology
$1.98
+4.76%
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ c…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
11% return in May, -4% avg return in past 3 year May month.
18% return in 2026, -37% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 45% | -40% | 12% | -10% | 11% | – | – | – | – | – | – | – | 18% |
| 25 | -2% | 4% | 14% | 9% | -3% | 3% | -8% | -2% | 4% | -6% | -7% | -52% | -46% |
| 24 | 2% | -7% | -3% | -35% | 6% | 7% | -3% | -11% | -12% | 13% | -26% | -7% | -76% |
| 23 | 36% | -21% | 7% | -12% | -13% | 83% | -11% | 4% | -13% | -12% | -40% | 3% | 12% |
| 22 | -14% | -15% | 25% | 4% | -18% | -21% | 18% | -15% | -1% | 7% | -7% | -3% | -40% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Downtrend · Uptrend
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is headquartered in Huntsville, Alabama.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$25.03M
P/E ratio
—
52W high
$7.92
52W low
$1.22
Volume
1,94,287
Beta
0.04
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Serina Therapeutics, Inc. share price today?
- Serina Therapeutics, Inc. (SER) last traded around $1.98 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SER have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SER. Download the app for real-time alerts.
- How can I analyze Serina Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.